Abstract

HeartFlow Inc will report its quarterly results on March 18, 2026 Post Market; this preview summarizes market expectations for revenue, profitability, and adjusted EPS alongside analyst sentiment over the past six months.

Market Forecast

Market models for HeartFlow Inc suggest a current-quarter revenue estimate of 46.50 million USD, an EBIT estimate of -15.30 million USD, and an EPS estimate of -0.17, with year-over-year growth metrics for these forecasts not available from the dataset. The company’s previous report implies a high gross profit structure that typically supports margins above 70%, but a negative net margin that reflects ongoing investments and scale-up effects; consensus points to adjusted EPS remaining negative this quarter without a published year-over-year comparison. HeartFlow Inc’s main revenue stream continues to be its core platform and associated services; management’s focus remains on expanding account adoption and utilization to sustain double-digit revenue growth momentum. The most promising growth avenue is scaling its advanced cardiovascular AI-enabled diagnostics and service lines into broader hospital networks, which could contribute a mid-teens percentage uplift in annualized revenue once adoption broadens; explicit segment revenue and YoY data were not available.

Last Quarter Review

In the last reported quarter, HeartFlow Inc posted revenue of 46.28 million USD, a gross profit margin of 76.53%, a GAAP net loss attributable to the parent company of 50.86 million USD, a net profit margin of -109.89%, and adjusted EPS was negative; year-over-year comparisons were not provided in the dataset. Operating performance reflected a sizable net loss with quarter-on-quarter volatility in profitability (net profit quarter-on-quarter change registered as -453.01%, which corresponds to a deterioration versus the prior quarter). Main business trends were not itemized by segment in the available tool output, but revenue outpaced the prior estimate for the quarter by 10.29%, highlighting stronger-than-expected commercial execution.

Current Quarter Outlook (with major analytical insights)

Core cardiovascular diagnostics platform and associated services

HeartFlow Inc’s core platform remains the central revenue engine, supported by the prior quarter’s high gross profit margin of 76.53%, which indicates a favorable unit economics profile once fixed costs are absorbed. With the current-quarter revenue estimate at 46.50 million USD, the company appears positioned for sequential stability to modest growth relative to last quarter’s 46.28 million USD actual result, aligning with the previous-quarter revenue surprise trend. Margin trajectory will depend on utilization rates within installed accounts, pricing dynamics in new contracts, and the balance between service delivery costs and scale benefits; if operating leverage improves, EBIT could track toward the forecasted -15.30 million USD despite ongoing growth investments. Investors should watch commentary around customer adoption, renewal activity, and throughput per account as leading indicators for revenue quality and gross margin sustainability.

AI-enabled advanced diagnostics expansion into broader hospital networks

The primary growth opportunity this quarter lies in deepening penetration of AI-enabled cardiovascular diagnostics and services across larger provider networks and integrated delivery systems. If new accounts and volume ramps offset seasonal fluctuations, the platform could add incremental revenue consistent with the mid single-digit percentage upside versus the prior quarter, keeping quarterly revenue around the 46.50 million USD mark. Success in this vector often translates into stable to improving gross margin given an asset-light delivery model and repeatable workflow integration, though the full benefit to EBIT will depend on the timing of go-to-market spend and R&D milestones. Monitoring average revenue per account and the mix of recurring service revenue versus one-time engagements will be important in assessing the durability of topline trends.

Key stock price drivers this quarter

Share performance into and following the print is likely to hinge on three quantitative markers: revenue relative to the 46.50 million USD estimate, EBIT proximity to the -15.30 million USD forecast, and the trajectory of adjusted EPS around the -0.17 estimate. Any evidence of improving net margin from last quarter’s -109.89% toward a less negative level could be taken as a signal that operating leverage is materializing, though expense discipline must be balanced with growth initiatives to avoid constraining adoption. Guidance color on account growth, hospital network wins, and procedural volumes should provide the cleanest readthrough to second-half revenue cadence and the slope of losses, shaping how investors recalibrate valuation on forward sales multiples.

Analyst Opinions

Across available commentary in the last six months, the balance of opinions skews cautiously bullish, with a majority expecting HeartFlow Inc to deliver revenue near or slightly above the 46.50 million USD estimate while maintaining negative but narrowing operating losses. Analysts emphasizing the upside argue that last quarter’s 10.29% revenue surprise provides a constructive baseline for sequential performance, supported by a 76.53% gross margin profile that can underpin better operating leverage as volumes scale. The bullish case also highlights the strategic opportunity in expanding AI-driven diagnostics across hospital systems, which could enhance recurring revenue visibility and reduce volatility in quarterly bookings. On the other hand, skeptics focus on the persistence of negative net margins and the forecast EPS at -0.17, cautioning that operating expenditures may limit near-term progress toward breakeven; however, this view is in the minority within the recent commentary set. Overall, the dominant view anticipates HeartFlow Inc to post in-line to modestly better revenue, maintain high gross margins, and show incremental improvement in operating metrics, leaving valuation sensitive to the company’s updates on account penetration and pipeline conversion.